{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:26:41Z","timestamp":1794547601324,"version":"4.9.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.eclinm.2025.103340","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:27:17Z","timestamp":1757777237000},"page":"103340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The national and subnational burden of Hodgkin Lymphoma (HL) in Italy from 1990 to 2023: results from the Global Burden of Disease Study 2023"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3372-2248","authenticated-orcid":false,"given":"Roberto","family":"Passera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Zamagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6930-4297","authenticated-orcid":false,"given":"Elisa","family":"Fabbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bauckneht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Carreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihajlo","family":"Jakovljevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"La Vecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Ledda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Minervini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7774-548X","authenticated-orcid":false,"given":"Lorenzo","family":"Monasta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2025.103340_bib1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/095952873201700106","article-title":"On some morbid appearances of the absorbent glands and spleen","volume":"17","author":"Hodgkin","year":"1832","journal-title":"Med Chir Trans"},{"key":"10.1016\/j.eclinm.2025.103340_bib2","series-title":"World Health organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues","author":"Jaffe","year":"2001"},{"key":"10.1016\/j.eclinm.2025.103340_bib3","series-title":"Il giardino dei Finzi-Contini","author":"Bassani","year":"1962"},{"issue":"21","key":"10.1016\/j.eclinm.2025.103340_bib4","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A prognostic score for advanced hodgkin\u2019s disease. International prognostic factors project on advanced Hodgkin\u2019s disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N Engl J Med"},{"issue":"27","key":"10.1016\/j.eclinm.2025.103340_bib5","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103340_bib6","doi-asserted-by":"crossref","first-page":"iv19","DOI":"10.1093\/annonc\/mdy080","article-title":"Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Eichenauer","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eclinm.2025.103340_bib7","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.eclinm.2025.103340_bib8","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.eclinm.2025.103340_bib9","series-title":"Clinical Practice guidelines in Oncology: hogdkin lymphoma, version 2","year":"2025"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103340_bib10","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103340_bib11","first-page":"12","article-title":"Cancer statistics, 2025","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eclinm.2025.103340_bib12","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2025.103340_bib13","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","article-title":"Guidelines for accurate and transparent health estimates reporting: the GATHER statement","volume":"388","author":"Stevens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2025.103340_bib14","series-title":"R: a language and environment for statistical computing","year":"2017"},{"key":"10.1016\/j.eclinm.2025.103340_bib15","series-title":"Protocol for the global burden of diseases, injuries and risk factors study (GBD)","year":"2024"},{"key":"10.1016\/j.eclinm.2025.103340_bib19","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2025.103340_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00432-021-03824-y","article-title":"Estimating the global burden of Epstein-Barr Virus-related cancers","volume":"148","author":"Wong","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103340_bib21","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1097-0142(197507)36:1<252::AID-CNCR2820360128>3.0.CO;2-7","article-title":"Combination chemotherapy of Hodgkin\u2019s disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP","volume":"36","author":"Bonadonna","year":"1975","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103340_bib22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0950-3536(96)80018-7","article-title":"The epidemiology of Hodgkin\u2019s disease","volume":"9","author":"Glaser","year":"1996","journal-title":"Baillieres Clin Haematol"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103340_bib23","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1093\/annonc\/9.suppl_5.S45","article-title":"The many faces of Hodgkin\u2019s disease around the world: what have we learned from its pathology?","volume":"9","author":"Harris","year":"1998","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103340_bib24","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a034819","article-title":"Epidemiology and etiology of leukemia and lymphoma","volume":"10","author":"Bispo","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.eclinm.2025.103340_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-022-01281-9","article-title":"Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis","volume":"15","author":"Huang","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.eclinm.2025.103340_bib26","first-page":"116","article-title":"Hodgkin lymphoma: a review and update on recent progress","volume":"68","author":"Shanbhag","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eclinm.2025.103340_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.blre.2018.07.003","article-title":"Evolution of survivorship in lymphoma, myeloma and leukemia: metamorphosis of the field into long term follow-up care","volume":"33","author":"Damlaj","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.eclinm.2025.103340_bib28","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/ajh.25856","article-title":"Hodgkin lymphoma: a 2020 update on diagnosis, risk-stratification, and management","volume":"95","author":"Ansell","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.eclinm.2025.103340_bib29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41408-021-00518-z","article-title":"Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapies","volume":"11","author":"Mohty","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.eclinm.2025.103340_bib30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/ijc.2910080203","article-title":"Epidemiologic patterns of Hodgkin\u2019s disease","volume":"8","author":"Correa","year":"1971","journal-title":"Int J Cancer"},{"issue":"S1","key":"10.1016\/j.eclinm.2025.103340_bib31","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/s00259-003-1154-9","article-title":"Epidemiology of Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma","volume":"30","author":"Swerdlow","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.eclinm.2025.103340_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/hon.723","article-title":"Epidemiology of Hodgkin\u2019s disease: a review","volume":"22","author":"Cartwright","year":"2004","journal-title":"Hematol Oncol"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103340_bib33","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1532\/IJH97.05184","article-title":"Epidemiology and pathologic features of Hodgkin lymphoma","volume":"83","author":"Shin-ichi","year":"2006","journal-title":"Int J Hematol"},{"key":"10.1016\/j.eclinm.2025.103340_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.semradonc.2009.09.006","article-title":"Hodgkin lymphoma across the age spectrum: epidemiology, therapy, and late effects","volume":"20","author":"Punnett","year":"2010","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.eclinm.2025.103340_bib35","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(22)01438-6","article-title":"The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019","volume":"400","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2025.103340_bib36","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019","volume":"8","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eclinm.2025.103340_bib37","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0140-6736(24)00476-8","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2025.103340_bib38","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2025.103340_bib39","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","article-title":"Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study","volume":"403","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103340_bib40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-019-0799-1","article-title":"Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study","volume":"12","author":"Zhou","year":"2019","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.eclinm.2025.103340_bib41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41408-023-00853-3","article-title":"Global burden of hematologic malignancies and evolution patterns over the past 30 years","volume":"13","author":"Zhang","year":"2023","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.eclinm.2025.103340_bib42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.puhe.2023.11.023","article-title":"The global burden of lymphoma: estimates from the Global Burden of Disease 2019 study","volume":"226","author":"Shen","year":"2024","journal-title":"Public Health"},{"key":"10.1016\/j.eclinm.2025.103340_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.dialog.2024.100182","article-title":"Global spatiotemporal distributions of lymphoma from 1990 to 2019: a Joinpoint regression analysis based on the global burden of disease study 2019, and projections until 2044","volume":"4","author":"Liu","year":"2024","journal-title":"Dialogues Health"},{"key":"10.1016\/j.eclinm.2025.103340_bib44","author":"Pu"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103340_bib45","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.33948","article-title":"Global patterns of Hodgkin lymphoma incidence and mortality in 2020 and a prediction of the future burden in 2040","volume":"150","author":"Singh","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103340_bib49","doi-asserted-by":"crossref","first-page":"e645","DOI":"10.1016\/S2468-2667(19)30189-6","article-title":"Italy\u2019s health performance, 1990-2017: findings from the global burden of disease study 2017","volume":"4","year":"2019","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.eclinm.2025.103340_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-79176-3","article-title":"National burden of cancer in Italy, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"10","author":"Bosetti","year":"2020","journal-title":"Sci Rep"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258953702500272X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258953702500272X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:07:07Z","timestamp":1794546427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258953702500272X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":44,"alternative-id":["S258953702500272X"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103340","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The national and subnational burden of Hodgkin Lymphoma (HL) in Italy from 1990 to 2023: results from the Global Burden of Disease Study 2023","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103509","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103475","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103508","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103340"}}